340 related articles for article (PubMed ID: 30518533)
1. Identification of ILK as a critical regulator of VEGFR3 signalling and lymphatic vascular growth.
Urner S; Planas-Paz L; Hilger LS; Henning C; Branopolski A; Kelly-Goss M; Stanczuk L; Pitter B; Montanez E; Peirce SM; Mäkinen T; Lammert E
EMBO J; 2019 Jan; 38(2):. PubMed ID: 30518533
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
3. The β
Kumaravel S; Abbey CA; Bayless KJ; Chakraborty S
Am J Physiol Cell Physiol; 2020 Dec; 319(6):C1045-C1058. PubMed ID: 33052069
[TBL] [Abstract][Full Text] [Related]
4. Mechanoinduction of lymph vessel expansion.
Planas-Paz L; Strilić B; Goedecke A; Breier G; Fässler R; Lammert E
EMBO J; 2012 Feb; 31(4):788-804. PubMed ID: 22157817
[TBL] [Abstract][Full Text] [Related]
5. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms.
Zhang Y; Ulvmar MH; Stanczuk L; Martinez-Corral I; Frye M; Alitalo K; Mäkinen T
Nat Commun; 2018 Apr; 9(1):1296. PubMed ID: 29615616
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-2 mediates lymphangiogenesis of colorectal carcinoma via a VEGFC/VEGFR3 independent signaling.
Ou JJ; Wei X; Peng Y; Zha L; Zhou RB; Shi H; Zhou Q; Liang HJ
Cancer Lett; 2015 Mar; 358(2):200-209. PubMed ID: 25543087
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
Harris AR; Perez MJ; Munson JM
BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
[TBL] [Abstract][Full Text] [Related]
10. Epsin deficiency promotes lymphangiogenesis through regulation of VEGFR3 degradation in diabetes.
Wu H; Rahman HNA; Dong Y; Liu X; Lee Y; Wen A; To KH; Xiao L; Birsner AE; Bazinet L; Wong S; Song K; Brophy ML; Mahamud MR; Chang B; Cai X; Pasula S; Kwak S; Yang W; Bischoff J; Xu J; Bielenberg DR; Dixon JB; D'Amato RJ; Srinivasan RS; Chen H
J Clin Invest; 2018 Aug; 128(9):4025-4043. PubMed ID: 30102256
[TBL] [Abstract][Full Text] [Related]
11. TNFR1 mediates TNF-α-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling.
Ji H; Cao R; Yang Y; Zhang Y; Iwamoto H; Lim S; Nakamura M; Andersson P; Wang J; Sun Y; Dissing S; He X; Yang X; Cao Y
Nat Commun; 2014 Sep; 5():4944. PubMed ID: 25229256
[TBL] [Abstract][Full Text] [Related]
12. Two Birds, One Stone: Double Hits on Tumor Growth and Lymphangiogenesis by Targeting Vascular Endothelial Growth Factor Receptor 3.
Hsu MC; Pan MR; Hung WC
Cells; 2019 Mar; 8(3):. PubMed ID: 30901976
[TBL] [Abstract][Full Text] [Related]
13. H-, N- and Kras cooperatively regulate lymphatic vessel growth by modulating VEGFR3 expression in lymphatic endothelial cells in mice.
Ichise T; Yoshida N; Ichise H
Development; 2010 Mar; 137(6):1003-13. PubMed ID: 20179099
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.
Xu Y; Yuan L; Mak J; Pardanaud L; Caunt M; Kasman I; Larrivée B; Del Toro R; Suchting S; Medvinsky A; Silva J; Yang J; Thomas JL; Koch AW; Alitalo K; Eichmann A; Bagri A
J Cell Biol; 2010 Jan; 188(1):115-30. PubMed ID: 20065093
[TBL] [Abstract][Full Text] [Related]
15. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
[TBL] [Abstract][Full Text] [Related]
16. Arf6 in lymphatic endothelial cells regulates lymphangiogenesis by controlling directional cell migration.
Lin YC; Ohbayashi N; Hongu T; Katagiri N; Funakoshi Y; Lee H; Kanaho Y
Sci Rep; 2017 Sep; 7(1):11431. PubMed ID: 28900118
[TBL] [Abstract][Full Text] [Related]
17. Ras/MAPK signaling modulates VEGFR-3 expression through Ets-mediated p300 recruitment and histone acetylation on the Vegfr3 gene in lymphatic endothelial cells.
Ichise T; Yoshida N; Ichise H
PLoS One; 2012; 7(12):e51639. PubMed ID: 23284731
[TBL] [Abstract][Full Text] [Related]
18. A dual role for Tbx1 in cardiac lymphangiogenesis through genetic interaction with Vegfr3.
Martucciello S; Turturo MG; Bilio M; Cioffi S; Chen L; Baldini A; Illingworth E
FASEB J; 2020 Nov; 34(11):15062-15079. PubMed ID: 32951265
[TBL] [Abstract][Full Text] [Related]
19. S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress-dependent VEGF-C signaling.
Geng X; Yanagida K; Akwii RG; Choi D; Chen L; Ho Y; Cha B; Mahamud MR; Berman de Ruiz K; Ichise H; Chen H; Wythe JD; Mikelis CM; Hla T; Srinivasan RS
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32544090
[TBL] [Abstract][Full Text] [Related]
20. VEGFR3 is required for button junction formation in lymphatic vessels.
Jannaway M; Iyer D; Mastrogiacomo DM; Li K; Sung DC; Yang Y; Kahn ML; Scallan JP
Cell Rep; 2023 Jul; 42(7):112777. PubMed ID: 37454290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
